Pharmafile Logo
Pharmafocus logo
Advanced Search

Pharma-biotech partnerships: creative approaches to doing the deal

January 26, 2011
Research and Development Susan Aldridge, biotech, biotech partnerships, pharma partnering

Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …

Feature

Sanofi buys into cancer antibody research

January 26, 2011
Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research

Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …

News

J&J posts negative growth as pharma sales stall

January 26, 2011
Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta

Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …

News

Dr Marie-Paule Richard joins AiCuris as CMO

January 26, 2011
Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …

Appointment

Eisai sepsis drug fails in phase III

January 26, 2011
Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …

News

NHS competition will prevent postcode lottery, says Lansley

January 25, 2011
NHS, NHS reforms, postcode prescribing

The government has pledged that value-based competition in the NHS will create “the very opposite of the postcode lottery”, following …

News
Amgen HQ

Amgen signs $1 billion cancer biotech deal

January 25, 2011
Research and Development Amgen, BioVex, OncoVEXGM-CSF, cancer vaccine

Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …

News

David Jukes promoted to president of Univar Europe

January 25, 2011
Manufacturing and Production David Jukes, John van Osch, manufacturing and production, univar

Chemical distributor Univar has promoted David Jukes to president of its European operations. He replaces John van Osch who is …

Appointment

Genzyme plans new Belgium facility

January 25, 2011
Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa

US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …

News

Bio and clinical plants feature in 2011 FOYA honours

January 25, 2011
Manufacturing and Production MedImmune, Merck & Co, Novartis, Pfizer, Roche, Shire HGT, pharma manufacturing

Three US and three European manufacturing plants have been shortlisted for the annual Facility of the Year awards, with the …

News
GlaxoSmitKline's headquarters

GSK skin cancer drugs moves into phase III

January 25, 2011
Research and Development BRAF V600 mutation, Cancer, Duchenne Muscular Dystrophy, GSK, GSK1120212, GSK2118436, GSK968, GlaxoSmithKline, melanoma, skin cancer

GlaxoSmithKline has begun late-stage trials of two new drugs for advanced or metastatic melanoma patients. GSK2118436 and GSK1120212 are being …

News

SHL GM Frank Isaksson to speak at the 2011 Injectable Drug Delivery Conference

January 25, 2011
Manufacturing and Production, Medical Communications auto injector, autoinjector, frank isaksson, injectable drug delivery

With a steadily increasing number of biologics coming to market, the demand for auto injectors and similar devices continues to …

News
Press release

Axon makes US appointment

January 24, 2011
Medical Communications AXON Communications, Mark Khan, appointment, medical communications

Richmond, UK-based comms agency Axon Communications has expanded its stateside operations, appointing Mark Khan as VP of client services and …

Appointment
Blog footer

Digital Pharma: Pfizer UK’s online surgery (case study)

January 24, 2011
Medical Communications Digital Pharma blog, Facebook advertising, Google Adwords, ManMOT, PR, Pfizer, Twitter, blogs, male health

Pfizer UK’s online male health clinic Man MOT was launched last summer to offer men confidential advice and information about …

Feature

Novartis MS drug steals march over Merck rival

January 24, 2011
Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis

Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …

News

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011
Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …

News

Contract research news in brief

January 24, 2011
Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody

PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …

News

OgilvyHealthPR appoints Wendy Gerber and Tania Kouprach-Rolandi

January 24, 2011
Medical Communications OgilvyHealthPR, Tania Kouprach-Rolandi, Wendy Gerber, appointment, medical communications

OgilvyHealthPR has strengthened its London team with the appointments of Wendy Gerber and Tania Kouprach-Rolandi, who will focus on HIV, …

Appointment
scope_medical_sidrah

Ian Dickety and Sidrah Qureshi join ScopeMedical

January 21, 2011
Medical Communications Ian Dickety, ScopeMedical, Sidrah Qureshi, appointments, medical communications

Kent-based med comms agency ScopeMedical has made two new appointments to its team.Starting at the agency are junior digital developer …

Appointment
ABPI Code of Practice

Boehringer’s Pradaxa advertising breaches Code

January 21, 2011
Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis

Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026